GLP1-s and Beyond: Weight Loss Medications in your Bariatric Endoscopy Practice | March 2024-GLP1-s and Beyond Weight Loss Medications in Your Bariatric Endoscopy Practice

Video Transcription

Video Summary

The webinar discussed the complexities of obesity and the use of GLP-1 agonists for weight management and diabetes control. Dr. Narang and Dr. Phan highlighted the challenges of obesity treatment and the efficacy of medications like semaglutide and terzepatide. They emphasized the importance of lifestyle changes alongside medication for sustained weight loss. The webinar also covered the integration of GLP-1 therapy with bariatric endoscopy procedures like intragastric balloons and sleeve gastrectomy to address insufficient weight loss or weight regain post-procedure. Adverse events and effective management strategies were discussed, underlining the need for a comprehensive approach to treating obesity. In another presentation, Dr. Narang and Dr. Khan addressed counseling for GLP-1 agonist side effects, management strategies, and considerations for patients with specific conditions like IBD and poorly controlled diabetes. They also discussed the combination of GLP-1 agonists with bariatric endoscopy procedures for rapid weight loss and upcoming ESG devices. Individualized treatment plans based on patient needs were highlighted throughout both presentations.

Meta Tag

Concept Obesity Epidemic

Concept GLP-1 Receptor Agonist

Concept Anti-Obesity Medication

Concept Patient Selection

Concept Adverse Event

Keywords

obesity

GLP-1 agonists

weight management

diabetes control

semaglutide

terzepatide

lifestyle changes

bariatric endoscopy procedures

intragastric balloons

sleeve gastrectomy

Obesity Epidemic

GLP-1 Receptor Agonist

Anti-Obesity Medication

Patient Selection

Adverse Event